Evidence Hub

The role of ferroptosis in osteoporosis: a cellular perspective on osteoblast, osteoclast and osteocyte dysfunction

Murusuri AB, Tang J

Frontiers in endocrinology, 2026

5 citations

Abstract

Osteoporosis is characterized by an imbalance between bone resorption and bone formation, leading to the loss of both trabecular and cortical bone mass, ultimately resulting in an increased risk of fractures. Osteoporosis represents a major global health burden, predominantly affecting elderly individuals and postmenopausal women. With the continued growth of the aging population, the prevalence of osteoporosis is expected to increase, highlighting the urgent need for more effective therapeutic strategies. Ferroptosis, a recently characterized form of iron-dependent, non-apoptotic cell death, has emerged as an important mechanism contributing to the pathogenesis of osteoporosis. A better understanding of ferroptosis may therefore provide new insights into therapeutic development. This review summarizes current evidence regarding the role of ferroptosis in osteoporosis, with particular focus on its effects on osteoblasts, osteoclasts, and osteocytes, as well as the impact of aging, estrogen deficiency, diabetes, glucocorticoid exposure, and obesity on ferroptosis in osteogenic cells.

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free